Play Video

OIS

The Ophthalmology Innovation Summit (OIS) was conceptualized and developed by ophthalmologist/venture capitalist Emmett Cunningham of Clarus Funds now Blackstone Life Sciences. To make his vision for OIS a reality, Emmett enrolled legendary venture capitalists, Bill Link of Versant Ventures/Flying L Partners to Co-Chair the summits. The addition of experienced conference producer, Craig Simak brought the event to life in 2009.

Learn More

QUOTE OF THE MONTH

“It is better to light a candle than curse the darkness.” - Eleanor Roosevelt
(referenced by Mark Blumenkranz, MD on his recent OIS Retina Podcast)

EVENT UPDATES

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LEARN MORE

The 2020 Ophthalmology Year in Review will take a look back at all of the notable deals, approvals, IPOs and M&A transactions, plus provide deeper insights and perspectives from investors, clinical thought leaders and industry executives.

LEARN MORE

TRENDING AT OIS

Discover the latest trending news, podcasts, videos from OIS covering corporate leaders and innovators.

Nature as an Inspiration for Innovation
November 18, 2020
A Lot of Skill and a Little Luck: Dr. Steven Schwartz’s Journey in Ophthalmology Innovation
November 10, 2020
The Steve Jobs of Ophthalmology
November 3, 2020
Doctor to Doctor with Joe Boorady, OD – President and CEO, Euclid Systems Corporation
October 27, 2020
Dr. Steve Pakola’s Perspective on the Transformative Power of Advanced Therapeutics
October 20, 2020
Tarsus Closes IPO, Starts Phase IIb/III Trials for Demodex Blepharitis Drop
November 18, 2020
Exploring Why Pharma Hesitates to Embrace Drug-Delivery Methodologies
November 10, 2020
Equinox Founder Berdahl Moves Sideways, But Not Away, to Keep Company Growing
November 3, 2020
The Next Wave of Glaucoma Innovation: Moving Beyond MIGS
October 28, 2020
COVID Can’t Lock Down Innovation in Glaucoma
October 20, 2020
Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs
August 18, 2020
Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery
April 29, 2020
OIS Index Rallies Back from COVID-Driven Decline
July 9, 2020
OIS Index Posts a Strong Finish to 2019
January 9, 2020
OIS Index Outperforms
December 4, 2019
OIS Index on Positive Upswing
November 6, 2019
OIS Index Deep in Bear Territory in Q3
October 2, 2019
Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Apply Today

The OIS All Stars of Ophthalmic Innovation

This is the inaugural ranking of individuals working to transform the current state of vision care. The nominees will be reviewed by a committee of OIS faculty, advisors and journalists. Once selected, the list of OIS All Stars will be published and widely promoted. Nominate your colleagues & peers here.

TESTIMONIALS

Why People Attend OIS

Daphne-Haim-Langford-PhD-OIS-Israel

TOM MITRO

PRESIDENT & COO

YARI MITCHELL

VP, GLOBAL MEDICAL AFFAIRS

JAG DOSANJH

SENIOR VICE PRESIDENT

SUBSCRIBE TO OUR NEWSLETTER

Get the Latest News Ophthalimc Innovation To Your Inbox.